{"id":3455,"date":"2023-06-19T12:58:02","date_gmt":"2023-06-19T10:58:02","guid":{"rendered":"https:\/\/rythmologie.fr\/index\/?p=3455"},"modified":"2023-06-19T12:58:02","modified_gmt":"2023-06-19T10:58:02","slug":"newsletter-juin-2023-first-in-man-experience-with-the-impella-5-0-5-5-hemodynamic-support-device-for-high-risk-patients-with-advanced-heart-failure-undergoing-vt-ablation-by-jakub-sroubek","status":"publish","type":"post","link":"https:\/\/rythmologie.fr\/index\/newsletter-juin-2023-first-in-man-experience-with-the-impella-5-0-5-5-hemodynamic-support-device-for-high-risk-patients-with-advanced-heart-failure-undergoing-vt-ablation-by-jakub-sroubek\/","title":{"rendered":" Newsletter Juin 2023 &#8211; First-in-man ..."},"content":{"rendered":"<p>[vc_row][vc_column css=&#8221;.vc_custom_1663235123898{margin-top: 0px !important;border-top-width: 0px !important;background-color: rgba(255,255,255,0.1) !important;*background-color: rgb(255,255,255) !important;}&#8221;]<div id=\"ultimate-heading-973969fc641edc51b\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-973969fc641edc51b uvc-9920  uvc-heading-default-font-sizes\" data-hspacer=\"no_spacer\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-973969fc641edc51b h2'  data-responsive-json-new='{\"font-size\":\"\",\"line-height\":\"\"}' ><h2 style=\"--font-weight:theme;margin-top:20px;margin-bottom:20px;\">Newsletter Groupe Rythmologie \u2013 Stimulation cardiaque de la SFC<\/h2><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-973969fc641edc51b .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"\",\"line-height\":\"\"}'  style=\"font-weight:normal;margin-top:20px;margin-bottom:20px;\">Juin 2023<\/div><\/div>[vc_empty_space height=&#8221;24px&#8221;][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;#e42925&#8243;][\/vc_column][\/vc_row][vc_row][vc_column]<div id=\"ultimate-heading-631669fc641edc576\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-631669fc641edc576 uvc-1395 \" data-hspacer=\"no_spacer\"  data-halign=\"left\" style=\"text-align:left\"><div class=\"uvc-heading-spacer no_spacer\" style=\"top\"><\/div><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-631669fc641edc576 h3'  data-responsive-json-new='{\"font-size\":\"\",\"line-height\":\"desktop:24px;\"}' ><h3 style=\"--font-weight:theme;color:#e42925;margin-top:24px;margin-bottom:24px;\">First-in-man Experience with the Impella 5.0\/5.5 Hemodynamic Support Device for High-Risk Patients with Advanced Heart Failure Undergoing VT Ablation By Jakub Sroubek<\/h3><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-631669fc641edc576 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"\",\"line-height\":\"\"}'  style=\"font-weight:normal;color:#000000;margin-top:24px;margin-bottom:24px;\"><\/p>\n<div class=\"page\" title=\"Page 2\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 4\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 4\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 7\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p style=\"font-weight: 400;\"><em>Rapport\u00e9 par <\/em><em>Frederic Sacher &#8211; Bordeaux<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p><\/div><\/div>[vc_empty_space height=&#8221;24px&#8221;][vc_column_text]<\/p>\n<h3 style=\"font-weight: 400;\"><span style=\"text-decoration: underline;\"><strong>But de l\u2019\u00e9tude <\/strong>:<\/span><\/h3>\n<p style=\"font-weight: 400;\">Rapporter l\u2019exp\u00e9rience de la Cleveland clinic dans l\u2019utilisation pr\u00e9ventive de l\u2019Impella 5.0\/5.5 chez les patients avec ablation de TV et insuffisance cardiaque.<\/p>\n<h3 style=\"font-weight: 400;\"><span style=\"text-decoration: underline;\"><strong>Design de l\u2019\u00e9tude\u00a0: <\/strong><\/span><\/h3>\n<p style=\"font-weight: 400;\">Observationnel avec comparaison au travers une population contr\u00f4le appari\u00e9e.<\/p>\n<h3 style=\"font-weight: 400;\"><strong><span style=\"text-decoration: underline;\">Crit\u00e8res d\u2019\u00e9valuation\u00a0:<\/span> <\/strong><\/h3>\n<p style=\"font-weight: 400;\">Crit\u00e8re composite comprenant le d\u00e9c\u00e8s, l\u2019implantation d\u2019une assistance circulatoire au long cours et\/ou la transplantation cardiaque. Les autres crit\u00e8res de jugement \u00e9taient les complications et la r\u00e9cidive de TV\/FV.<\/p>\n<h3 style=\"font-weight: 400;\"><span style=\"text-decoration: underline;\"><strong>Crit\u00e8res d\u2019inclusion\u00a0: <\/strong><\/span><\/h3>\n<p style=\"font-weight: 400;\">Pour le groupe Impella, tous les patients ayant eu une ablation de TV avec Impella \u00e0 la Cleveland clinic. Pour le groupe contr\u00f4le les patients appari\u00e9s qui ont eu une ablation de TV \u00e0 la Cleveland clinic sans assistance circulatoire.<\/p>\n<h3 style=\"font-weight: 400;\"><span style=\"text-decoration: underline;\"><strong>R\u00e9sultats\u00a0: <\/strong><\/span><\/h3>\n<p style=\"font-weight: 400;\">L\u2019Age moyen des patients dans les 2 groupes \u00e9taient de 66 ans avec une FEVG \u00e0 25% \u00e0 et une clairance de la cr\u00e9atinine moyenne de 72 ml\/min. La pr\u00e9sentation initiale \u00e9tait un orage rythmique dans 63%.<\/p>\n<p style=\"font-weight: 400;\">Les taux de complications \u00e9taient significativement plus important dans le groupe Impella (29% vs 2,4%\u00a0 \u2013 p=0,002). Durant un suivi moyen de 1,3 ans, le crit\u00e8re composite primaire (d\u00e9c\u00e8s, LVAD, transplantation cardiaque) n\u2019\u00e9tait pas significativement diff\u00e9rent : 54% dans le groupe Impella vs 61% dans le groupe contr\u00f4le. Il n\u2019y avait pas de diff\u00e9rence non plus sur les r\u00e9cidives de TV\/VF : 66% vs 60% respectivement.<\/p>\n<h3 style=\"font-weight: 400;\"><span style=\"text-decoration: underline;\"><strong>Discussion\u00a0: <\/strong><\/span><\/h3>\n<p style=\"font-weight: 400;\">Cette \u00e9tude confirme les pr\u00e9c\u00e9dentes qui ne montraient pas d\u2019int\u00e9r\u00eat \u00e0 l\u2019utilisation d\u2019une assistance circulatoire pr\u00e9ventive avant ablation de TV dans le but de pouvoir plus facilement cartographier les TV. Cette strat\u00e9gie n\u2019entraine pas de meilleur r\u00e9sultat mais \u00e0 plus de complication et coute plus ch\u00e8re. L\u2019assistance circulatoire avant une ablation de TV repose sur l\u2019ECMO pour des patients en ayant besoin par ailleurs (insuffisance cardiaque ou orage rythmique non contr\u00f4l\u00e9s). Sinon, l\u2019ablation de TV doit \u00eatre bas\u00e9e sur le traitement du substrat particuli\u00e8rement chez les patients tr\u00e8s fragiles.<\/p>\n<p>[\/vc_column_text][vc_empty_space height=&#8221;24px&#8221;][vc_empty_space height=&#8221;24px&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][vc_empty_space][vc_separator][vc_empty_space][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column css=&#8221;.vc_custom_1663235123898{margin-top: 0px !important;border-top-width: 0px !important;background-color: rgba(255,255,255,0.1) !important;*background-color: rgb(255,255,255) !important;}&#8221;][vc_empty_space height=&#8221;24px&#8221;][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;#e42925&#8243;][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=&#8221;24px&#8221;][vc_column_text] But de l\u2019\u00e9tude : Rapporter l\u2019exp\u00e9rience de la Cleveland clinic dans l\u2019utilisation pr\u00e9ventive de l\u2019Impella 5.0\/5.5 chez les patients avec ablation de TV et insuffisance cardiaque. Design de l\u2019\u00e9tude\u00a0: Observationnel avec comparaison au travers une population contr\u00f4le appari\u00e9e. Crit\u00e8res d\u2019\u00e9valuation\u00a0: Crit\u00e8re&hellip;<\/p>\n","protected":false},"author":2,"featured_media":3456,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,22],"tags":[],"class_list":["post-3455","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsletter","category-articles","category-31","category-22","description-off"],"_links":{"self":[{"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/posts\/3455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/comments?post=3455"}],"version-history":[{"count":2,"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/posts\/3455\/revisions"}],"predecessor-version":[{"id":3458,"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/posts\/3455\/revisions\/3458"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/media\/3456"}],"wp:attachment":[{"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/media?parent=3455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/categories?post=3455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rythmologie.fr\/index\/wp-json\/wp\/v2\/tags?post=3455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}